leflunomide has been researched along with foscarnet in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Waldman, WJ; Williams, JW | 1 |
Avery, RK; Bolwell, BJ; Curtis, J; Kalaycio, M; Kohn, D; Long, JR; Longworth, DL; Lurain, N; Mossad, SB; Pohlman, B; Taege, AJ; Waldman, WJ; Williams, JW; Yen-Lieberman, B | 1 |
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H | 1 |
Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ | 1 |
Behr, J; Giessen, C; Jäger, G; Kneidinger, N; Milger, K; Neurohr, C; Nitschko, H; Schramm, R; Striebinger, H; von Wulffen, W | 1 |
Ambrose, T; Butler, A; Carmichael, A; Duncan, S; English, S; Gkrania-Klotsas, E; Louis-Auguste, J; Massey, D; Middleton, S; Russell, N; Rutter, CS; Sharkey, LM; Woodward, JM | 1 |
Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E | 1 |
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L | 1 |
Al-Aloul, M; Fu, L; Jones, NP; Santhanakrishnan, K; Steeples, LR | 1 |
3 review(s) available for leflunomide and foscarnet
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load | 2013 |
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leflunomide; Lung Transplantation; Male; Middle Aged; Transplant Recipients | 2020 |
9 other study(ies) available for leflunomide and foscarnet
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
Topics: Antiviral Agents; Blotting, Northern; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endothelium, Vascular; Fibroblasts; Foscarnet; Gene Expression; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Time Factors; Transcription, Genetic; Umbilical Veins; Viral Proteins; Virus Replication | 1999 |
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Middle Aged; Salvage Therapy; Transplantation, Homologous; Viral Load | 2004 |
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome | 2012 |
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Leflunomide; Lung Transplantation; Monitoring, Immunologic; Transplant Recipients | 2014 |
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intestines; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Viremia | 2016 |
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation | 2016 |
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors | 2017 |